Pfizer agrees $40 million settlement over Trovan trial in Nigeria
This article was originally published in Scrip
Executive Summary
Pfizer will pay more than $40 million to Nigeria's Kano state government, concluding their long-running legal battle over the company's controversial 1996 Trovan (trovafloxacin) clinical trial.